oxbryta
pfizer europe ma eeig - voxelotor - anemia; anemia, hemolytic; anemia, sickle cell - other hematological agents - oxbryta is indicated for the treatment of haemolytic anaemia due to sickle cell disease (scd) in adults and paediatric patients 12 years of age and older as monotherapy or in combination with hydroxycarbamide.
resuscittor automatický oxylator®
cpr medical devices inc. don park road, markham ontario kanada -
metoprolol ratiopharm 25 mg
ratiopharm gmbh, nemecko - metoprolol - 58 - hypotensiva
metoprolol ratiopharm 50 mg
ratiopharm gmbh, nemecko - metoprolol - 58 - hypotensiva
metoprolol ratiopharm 200 mg
ratiopharm gmbh, nemecko - metoprolol - 58 - hypotensiva
bloxazoc 200 mg tablety s predĺženým uvoľňovaním
krka, d.d., novo mesto, slovinsko - metoprolol - 58 - hypotensiva
bloxazoc 100 mg tablety s predĺženým uvoľňovaním
krka, d.d., novo mesto, slovinsko - metoprolol - 58 - hypotensiva
bloxazoc 50 mg tablety s predĺženým uvoľňovaním
krka, d.d., novo mesto, slovinsko - metoprolol - 58 - hypotensiva
betaloc 1 mg/1 ml
recordati industria chimica e farmaceutica s.p.a., taliansko - metoprolol - 77 - sympatholytica